Treatment of Coagulopathy

Area of Science:

• Medicine
• Radiology
• Critical Care

Background:

• Bleeding is a significant risk in vascular and interventional radiology (VIR) procedures.
• Coagulopathic abnormalities are prevalent in critically ill patients requiring emergent VIR interventions.

Purpose of the Study:

• To enhance VIR physicians' clinical understanding of coagulopathies.
• To guide VIR physicians in providing recommendations for managing common coagulopathies.

Main Methods:

• Review of common anticoagulants, antithrombotic agents, and their reversal agents.
• Evaluation and management strategies for critical care coagulopathies (DIC, HIT, uremic platelet dysfunction, liver disease-related).
• Discussion on the role of blood product transfusions and management in low vs. high bleeding risk VIR procedures.

Main Results:

• Provides a comprehensive overview of coagulopathy management relevant to VIR.
• Highlights the importance of VIR physicians acting as clinicians in managing patient hemostasis.
• Offers guidance for timely VIR interventions in critically ill patients with coagulopathies.

Conclusions:

• Understanding and managing coagulopathies is crucial for VIR physicians.
• Effective management ensures timely and safe VIR interventions for critically ill patients.
• Empowers VIR physicians to guide primary teams in correcting hemostatic abnormalities.